Document is current

Any future updates will be listed below

Author Correction: Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease

Crossref DOI link: https://doi.org/10.1038/s41598-022-20899-w

Published Online: 2022-09-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark